Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.48T
24h Vol:
$6.11B
Dominance:
MSFT:4.77%
Stocklytics Platform
Instrument logo  TMO
Thermo Fisher Scientific
TMO
57 / 100
S&P500
$573.69arrow_drop_up4.61%$25.31

Performance History

Stocklytics logo
Key Stats
Open$549.15
Prev. Close$544.78
EPS15.47
Dividend$1.44
Next Earnings DateJul 15, 2024
Dividend Yield %0.29%
Market Cap$207.95B
PE Ratio35.45
LOWHIGH
Day Range543.15
552.85
52 Week Range415.60
603.82
Ratios
P/B Ratio4.62
Revenue$42.85B
Operating M. %18.66%
Earnings$5.99B
Earnings Growth %-13.86%
EBITDA Margin %25.20%
ROE %13.09%
EPS15.47

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

57vs 54. Market Avg.

All Score 57 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

TMOMARKET
Value3039
Quality5440
Ownership4117
Growth5546
Dividends3038
warning

Thermo Fisher Scientific 's Price growth average in the last 3 years of 4.37% is modest compared to market average of 5.58%. This indicates TMO could be a bad value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$731.33
24H (%)arrow_drop_up0.69%
24H ($)$5.02
MARKET CAP$690.55B
PRICE$491.23
24H (%)arrow_drop_down1.97%
24H ($)-$9.89
MARKET CAP$462.00B
PRICE$149.12
24H (%)arrow_drop_up0.81%
24H ($)$1.20
MARKET CAP$356.43B
PRICE$126.94
24H (%)arrow_drop_up0.92%
24H ($)$1.16
MARKET CAP$318.60B

About Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Marc N. Casper
Headquarters
Waltham
Employees
130000
Exchange
NYSE
add Thermo Fisher Scientific  to watchlist

Keep an eye on Thermo Fisher Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Thermo Fisher Scientific 's (TMO) price per share?

The current price per share for Thermo Fisher Scientific (TMO) is $548.38. The stock has seen a price change of $3.6 recently, indicating a 0.66% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Thermo Fisher Scientific (TMO)?

For Thermo Fisher Scientific (TMO), the 52-week high is $603.82, which is 10.11% from the current price. The 52-week low is $415.6, the current price is 31.95% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Thermo Fisher Scientific (TMO) a growth stock?

Thermo Fisher Scientific (TMO) has shown an average price growth of 4.37% over the past three years. It has received a score of 63 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Thermo Fisher Scientific as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Thermo Fisher Scientific (TMO) stock price performance year to date (YTD)?

As of the latest data, Thermo Fisher Scientific (TMO) has a year-to-date price change of 0.8%. Over the past month, the stock has experienced a price change of -5.96%. Over the last three months, the change has been -0.88%. Over the past six months, the figure is 18.73%. Looking at a longer horizon, the five-year price change stands at 111.66%.

help
Is Thermo Fisher Scientific (TMO) a profitable company?

Thermo Fisher Scientific (TMO) has a net income of $6B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 40.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.66% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $42.86B, although specific revenue growth data is currently not available. The gross profit is $17.56B. Operating income is noted at $6.86B. Furthermore, the EBITDA is $11.54B.

help
What is the market capitalization of Thermo Fisher Scientific (TMO)?

Thermo Fisher Scientific (TMO) has a market capitalization of $207.95B. The average daily trading volume is 1.38M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.